Granules India Inaugurates Two Advanced Centres of Excellence at IIT Hyderabad
Hyderabad: Granules India Limited has officially inaugurated two advanced Centres of Excellence at the Technology Research Park of the Indian Institute of Technology (IIT) Hyderabad. These centres are the Ascelis Center of Excellence for Peptide Development and Characterization and the Granules Center of Excellence for Particle Engineering.
Overview of the Centres
The inauguration ceremony was led by Dr. Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India, alongside Uma Chigurupati, Executive Director of Granules India Limited, and Prof. B. S. Murty, Director of IIT Hyderabad.
Ascelis Center of Excellence for Peptide Development and Characterization
Established under Ascelis Peptides, the Contract Development and Manufacturing Organization (CDMO) arm of Granules, this Centre aims to drive the development of cosmetic, therapeutic, and pharmaceutical peptides. This facility marks Ascelis’ first development and characterization site in India, equipped for comprehensive characterization of primary, secondary, and tertiary structures.
Granules Center of Excellence for Particle Engineering
This Centre focuses on advancing polymorph research, material science, and innovative drug delivery systems, including amorphous solid dispersions. It replaces previous external and ad-hoc development processes with a dedicated research platform that enhances formulation performance and supports the creation of proprietary technologies for regulated markets.
Significance of the Inauguration
Dr. Krishna Prasad Chigurupati emphasized the importance of scientific excellence and rigorous research in shaping Granules India’s long-term strategy. He stated, “The launch of these Centres of Excellence significantly strengthens our capabilities in peptides and advanced material sciences, areas that will define the next wave of pharmaceutical innovation.”
Objectives of the Centres
The primary objectives of the newly inaugurated Centres include:
- Enhancing capabilities in peptide development and characterization.
- Advancing research in polymorphs and material sciences.
- Accelerating breakthrough development in drug formulations.
- Building differentiated technologies that enhance global competitiveness.
- Delivering meaningful value to partners and patients worldwide.
Collaboration and Future Prospects
The Ascelis Center will collaborate closely with Granules’ Swiss-based research and development facility, Senn Chemicals. This partnership aims to integrate advanced analytical and process development capabilities in-house, ensuring a seamless workflow from research to production.
Impact on the Pharmaceutical Industry
The establishment of these Centres is expected to have a significant impact on the pharmaceutical industry by:
- Providing a robust platform for innovative drug development.
- Facilitating the transition from research to market-ready products.
- Enhancing the quality and efficacy of pharmaceutical formulations.
Conclusion
The inauguration of the Ascelis Center of Excellence for Peptide Development and Characterization and the Granules Center of Excellence for Particle Engineering marks a pivotal moment for Granules India. It reflects the company’s commitment to advancing pharmaceutical innovation through cutting-edge research and development. With specialized infrastructure and a focus on scientific excellence, Granules India is poised to enhance its position in the global pharmaceutical landscape.
Note: This article is intended for informational purposes only and is based on the latest updates regarding Granules India and its initiatives.
